Verified employee & interview reviews

Johnson & Johnson Reviews

New Brunswick, New Jersey

—/ 5

0 reviews

Johnson & Johnson (J&J) is an American multinational corporation and a global leader in the healthcare industry, renowned for its extensive research, development, and manufacturing of medical technologies and pharmaceutical products. Founded in 1886 by brothers Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson in New Brunswick, New Jersey, the company initially revolutionized healthcare by producing the world's first ready-to-use sterile surgical dressings and commercial first aid kits. Over its more than 135-year history, it grew into one of the largest and most diversified healthcare conglomerates globally. Historically, Johnson & Johnson operated through three primary divisions: Consumer Health, Pharmaceuticals, and Medical Devices. It became globally recognized for household consumer brands such as BAND-AID, Tylenol, Listerine, Neutrogena, and Johnson's Baby Powder. However, in a major strategic reorganization completed in 2023, J&J spun off its consumer health division into a standalone public company named Kenvue. This pivotal shift allowed Johnson & Johnson to focus entirely on its high-margin, technologically advanced core segments: Innovative Medicine and MedTech. The Innovative Medicine segment (formerly Janssen Pharmaceuticals) stands as the company's largest revenue driver. It focuses on developing cutting-edge, prescription-only therapies across critical therapeutic areas, including oncology, immunology, neuroscience, cardiovascular and metabolism, infectious diseases, and pulmonary hypertension. Notable blockbuster treatments developed or marketed by this division include Stelara for inflammatory diseases, Darzalex for multiple myeloma, and Xarelto for blood-clot prevention. The company also gained prominent recognition during the COVID-19 pandemic by developing a single-shot viral vector vaccine. The MedTech segment positions J&J as a global leader in medical devices and diagnostic equipment. This division innovates at the intersection of biology and advanced technology, providing specialized tools used by healthcare professionals worldwide. Its portfolio encompasses advanced surgical instrumentation, robotic-assisted surgery platforms, orthopaedic implants for joint reconstruction and trauma care, interventional solutions like catheters, and vision care products including Acuvue disposable contact lenses. Headquartered at One Johnson & Johnson Plaza in New Brunswick, New Jersey, the corporation maintains a massive global footprint, operating in over 60 countries and employing approximately 140,000 people. It is publicly traded on the New York Stock Exchange under the ticker symbol JNJ and is a prominent component of the Dow Jones Industrial Average. Under the leadership of Chief Executive Officer Joaquin Duato, who took the helm in January 2022, the company continues to invest heavily in research and development—frequently allocating over $14 billion annually to its pipeline—while advancing long-term sustainability and global health equity goals.